20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T77504 | JAK1/2/3 Inhibitor 1 | PKA | |
JAK1/2/3 Inhibitor 1 is a potent protein kinase inhibitor.JAK1/2/3 Inhibitor 1 has antitumor activity that inhibits the growth of a variety of cancer cell lines. It inhibits the growth of cancer cells by binding to the c... | |||
T39113L | Povorcitinib phosphate | JAK | |
Povorcitinib phosphate is a selective JAK1 inhibitor and can be used in studies about the treatment of cutaneous lupus erythematosus and Lichen planus. | |||
T9195 | SHR0302 | ARQ252 | Apoptosis , JAK |
SHR0302 (ARQ252) is a JAK inhibitor that binds JAK1 with stronger affinity than others (Selectivity for JAK1 is more than 10 times for JAK2, 77 times for JAK3, 420 times for Tyk2). | |||
T12266 | Ilginatinib | NS-018 | Tyrosine Kinases , JAK |
Ilginatinib (NS-018) is a highly active and orally bioavailable inhibitor of JAK2. | |||
T7503 | Upadacitinib | ABT-494 | JAK |
Upadacitinib (ABT-494) (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM. | |||
T12266L | Ilginatinib maleate | NS-018 maleate | Tyrosine Kinases , JAK |
Ilginatinib maleate (NS-018 maleate) is a highly active and orally bioavailable inhibitor of JAK2. | |||
T12266L2 | Ilginatinib hydrochloride | NS-018 hydrochloride | Tyrosine Kinases , JAK |
Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally bioavailable inhibitor of JAK2. | |||
T22338 | 2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide | GDC046 | Others , JAK |
2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide (GDC046), a potent lead analog, has good kinase selectivity, physicochemical properties and pharmacokinetic profile. | |||
T22142 | RO8191 | RO4948191,CDM-3008 | HCV Protease , HBV , JAK , IFNAR , STAT |
RO8191 (CDM-3008) (CDM-3008) is an agonist of interferon (IFN) receptor. | |||
T5049 | NVP-BSK805 | NVP-BSK805 2HCl,BSK 805 | Tyrosine Kinases , JAK |
NVP-BSK805 (BSK 805) is an ATP-competitive JAK2 inhibitor. | |||
T11706 | Londamocitinib | AZD4604 | JAK |
Londamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity. | |||
T1849 | Momelotinib | CYT11387,CYT387,LM-1149 | Apoptosis , JAK , Autophagy |
Momelotinib (LM-1149) is an orally bioavailable small-molecule inhibitor of Janus kinases 1 and 2 (JAK1/2) with IC50 of 11 nM/18 nM. JAK1/2 inhibitor CYT387 competes with JAK1/2 for ATP binding, which may result in inhib... | |||
T35899 | JAK1-IN-8 | JAK1-IN-8 | JAK |
JAK1-IN-8, a specific inhibitor of Janus kinase 1 (JAK1, IC50<500 nM). | |||
T3998 | Itacitinib | INCB39110,INCB039110 | JAK |
Itacitinib (INCB039110) is an orally bioavailable inhibitor of Janus-associated kinase 1 (JAK1) with potential antineoplastic activity. | |||
T1929 | Filgotinib | GLPG0634 | Tyrosine Kinases , JAK |
Filgotinib (GLPG0634) is a selective JAK1 inhibitor. The IC50 values against JAK1, JAK2, JAK3, and TYK2 are 10 nM, 28 nM, 810 nM, and 116 nM, respectively. | |||
T3043 | Ruxolitinib phosphate | INC424,INCB018424,INC 424 phosphate,Ruxolitinib (INCB-18424) phosphate,INCB018424 phosphate | Mitophagy , JAK , Autophagy |
Ruxolitinib phosphate (INCB018424)(INCB018424 phosphate) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3. | |||
T10431 | Golidocitinib | AZD4205 | JAK |
Golidocitinib (AZD4205) is a selective JAK1 inhibitor (IC50: 73 nM) and weakly inhibits JAK2/JAK3 (IC50: >14.7, >30 μM). | |||
T3080 | Pyridone 6 | Janus-Associated Kinase Inhibitor I,JAK Inhibitor,CMP 6,JAK Inhibitor I | Tyrosine Kinases , JAK |
Pyridone 6 (JAK Inhibitor)(CMP 6) is a potent and selective inhibitor of JAK1 (IC50=15 nM, murine JAK1), JAK2 (IC50=1 nM), JAK3 (Ki=5 nM), and Tyk2 (IC50=1 nM); displaying significantly weaker affinities (130 nM to 10 mM... | |||
TQ0037 | Abrocitinib | PF-04965842 | JAK |
Abrocitinib (PF-04965842) (PF-04965842) is a potent, specific and orally-active JAK1 inhibitor (IC50s: 29/803 nM for JAK1/2). | |||
T3076 | GLPG0634 analog | GLPG0634 analogue | Tyrosine Kinases , JAK |
GLPG0634 analog (GLPG0634 analogue) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for JAK1/2/3 and TYK2, respectively. |